Feedback of Individual Genetic Results to Research Participants: Is It Feasible in Europe?

Biopreservation and Biobanking

Volumn 14, Issue 3, 2016, Pages 241-248

  Budin Ljøsne, Isabelle ^a,b   Mascalzoni, Deborah ^c,d   Soini, Sirpa ^e   Machado, Helena ^f   Kaye, Jane ^g   Bentzen, Heidi Beate ^a,b   Rial Sebbag, Emmanuelle ^h   D'Abramo, Flavio ⁱ   Witt, Michał ^j   Schamps, Geneviève ^k   Katić, Višnja ^l   Krajnovic, Dusanca ^m   Harris, Jennifer R ⁿ  

^a UNIVERSITY OF OSLO   (Norway)

^b Norwegian Cancer Genomics Consortium   (Norway)

^c UPPSALA UNIVERSITY   (Sweden)

^d University of Lubeck   (Italy)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f UNIVERSITY OF COIMBRA   (Portugal)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h UNIVERSITÉ DE TOULOUSE   (France)

ⁱ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^j INSTITUTE OF HUMAN GENETICS   (Poland)

^k UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^l UNIVERSITY OF RIJEKA   (Croatia)

^m UNIVERSITY OF BELGRADE   (Serbia)

ⁿ NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSULTATION; CONTENT ANALYSIS; COST EFFECTIVENESS ANALYSIS; EUROPE; FUNDING; GENETICS; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESEARCH ETHICS; SOCIAL NETWORK; DUTY TO RECONTACT; ECONOMICS; ETHICS; INCIDENTAL FINDING; LEGISLATION AND JURISPRUDENCE; ORGANIZATION AND MANAGEMENT; PROFESSIONAL STANDARD; QUESTIONNAIRE;

DUTY TO RECONTACT; ETHICS COMMITTEES, RESEARCH; EUROPE; GENETIC RESEARCH; HUMANS; INCIDENTAL FINDINGS; SURVEYS AND QUESTIONNAIRES;

EID: 84973348811     PISSN: 19475535     EISSN: 19475543     Source Type: Journal    
DOI: 10.1089/bio.2015.0115     Document Type: Article

References (61)

1. Bredenoord AL, Kroes HY, Cuppen E, et al. Disclosure of individual genetic data to research participants: The debate reconsidered. Trends Genet 2011;27:41-47.
2. Wolf SM. Return of individual research results and incidental findings: Facing the challenges of translational science. Annu Rev Genomics Hum Genet 2013;14:557-577.
3. Knoppers BM, Zawati MH, Senecal K. Return of genetic testing results in the era of whole-genome sequencing. Nat Rev Genet 2015;16:553-559.
4. Shkedi-Rafid S, Dheensa S, Crawford G, et al. Defining and managing incidental findings in genetic and genomic practice. J Med Genet 2014;51:715-723.
5. van El CG, Cornel MC, Borry P, et al. Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur J Hum Genet 2013; 21(Suppl 1):S1-S5.
6. Claustres M, Kozich V, Dequeker E, et al. Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic). Eur J Hum Genet 2014;22:160-170.
7. Kaye J, Hurles M, Griffin H, et al. Managing clinically significant findings in research: The UK10K example. Eur J Hum Genet 2014; 22:1100-1104.
8. Haukkala A, Kujala E, Alha P, et al. The return of unexpected research results in a biobank study and referral to health care for heritable long QT syndrome. Public Health Genomics 2013;16:241-250.
9. Chakradhar S. Many returns: Call-ins and breakfasts hand back results to study volunteers. Nat Med 2015;21:304-306.
10. Genomics England. The 100,000 Genomes Project. Available at: www.genomicsengland.co.uk/the-100000-genomesproject/ Accessed August 31, 2015.
11. Estonian Genome Center, University of Tartu. Available at: www.geenivaramu.ee/en Accessed August 31, 2015.
12. Facio FM, Eidem H, Fisher T, et al. Intentions to receive individual results from whole-genome sequencing among participants in the ClinSeq study. Eur J Hum Genet 2013; 21:261-265.
13. Middleton A, Morley KI, Bragin E, et al. Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research. Eur J Hum Genet 2016;24:21-29.
14. Kaye J, Curren L, Anderson N, et al. From patients to partners: Participant-centric initiatives in biomedical research. Nat Rev Genet 2012;13:371-376.
15. Kullo IJ, Haddad R, Prows CA, et al. Return of results in the genomic medicine projects of the eMERGE network. Front Genet 2014;5:50.
16. Fullerton SM, Wolf WA, Brothers KB, et al. Return of individual research results from genome-wide association studies: Experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med 2012;14:424-431.
17. Johns AL, Miller DK, Simpson SH, et al. Returning individual research results for genome sequences of pancreatic cancer. Genome Med 2014;6:42.
18. Christensen KD, Roberts JS, Shalowitz DI, et al. Disclosing individual CDKN2A research results to melanoma survivors: Interest, impact, and demands on researchers. Cancer Epidemiol Biomarkers Prev 2011;20:522-529.
19. Lawrence L, Sincan M, Markello T, et al. The implications of familial incidental findings from exome sequencing: The NIH Undiagnosed Diseases Program experience. Genet Med 2014;16:741-750.
20. Keogh LA, Fisher D, Sheinfeld Gorin S, et al. How do researchers manage genetic results in practice? The experience of the multinational Colon Cancer Family Registry. J Community Genet 2014;5:99-108.
21. Klitzman R, Buquez B, Appelbaum PS, et al. Processes and factors involved in decisions regarding return of incidental genomic findings in research. Genet Med 2014;16:311-317.
22. BioSHaRE-EU (Biobank Standardisation and Harmonisation for Research Excellence in the European Union). Available at: www.bioshare.eu Accessed December 18, 2015.
23. BioSHaRE-EU. Catalogue of tools and services for data sharing. Available at: www.bioshare.eu/sites/default/files/ BioSHaRE%20Catalogue%20of%20tools%20and%20services %20for%20data%20sharing.pdf Accessed December 18, 2015.
24. COST. COST Action CHIP ME IS1303. Citizen's Health through public-private Initiatives: Public health, Market and Ethical perspectives. Available at: www.cost.eu/COST- Actions/isch/Actions/IS1303 Accessed August 31, 2015.
25. Open Space Technology. Available at: http://en.wikipedia. org/wiki/Open-Space-Technology Accessed March 31, 2015.
26. Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs 2008;62:107-115.
27. Council of Europe. Convention for the protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. Available at: http://conventions.coe. int/Treaty/en/Treaties/Html/164.htm Accessed March 31, 2015.
28. Council of Europe. Additional Protocol to the Convention on Human Rights and Biomedicine, concerning Biomedical Research. Available at: http://conventions.coe.int/Treaty/ en/Treaties/Html/195.htm Accessed March 31, 2015.
29. Council of Europe. Recommendation Rec(2006)4 of the Committee of Ministers to member states on research on biological materials of human origin. Available at: https:// wcd.coe.int/ViewDoc.jsp?id = 977859 Accessed March 31, 2015.
30. Riigi Teataja. Estonian Human Genes Research Act. Available at: www.riigiteataja.ee/en/eli/531102013003/consolide Accessed March 31, 2015.
31. LOI no 2012-300 du 5 mars 2012 relative aux recherches impliquant la personne humaine. Available at: www .legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000 025441587&dateTexte=&categorieLien=id Accessed March 31, 2015.
32. Ministry of Social Affairs and Health, Finland. Finnish Biobank Act 688/2012. Available at: www.finlex.fi/en/laki/ kaannokset/2012/en20120688.pdf Accessed March 31, 2015.
33. The Garante per la protezione dei dati personali. General Authorisation No. 8/2012 for the Processing of Genetic Data-13 December 2012. Available at: www.garanteprivacy .it/web/guest/home/docweb/-/docweb-display/docweb/2474250 Accessed March 31, 2015.
34. LOV 2008-06-20 nr 44. Lov om medisinsk og helsefaglig forskning (helseforskningsloven). Available at: www. lovdata.no/all/hl-20080620-044.html#28 Accessed March 31, 2015.
35. Norwegian Biotechnology Advisory Board. Forslag til veileder og retningslinjer for bruk av genomsekvensering og genomdata i klinikk og forskning. Available at: www .bioteknologiradet.no/filarkiv/2012/11/Veileder-genomsek vensering-091112-til-nett.pdf Accessed March 31, 2015.
36. Phg Foundation. Managing incidental and pertinent findings from WGS in the 100,000 Genomes Project. Available at: www.phgfoundation.org/file/13772/ Accessed August 31, 2015.
37. Medical Research Council and Wellcome Trust. Framework on the feedback of health-related findings in research. Available at: www.wellcome.ac.uk/stellent/groups/corporate site/@policy-communications/documents/web-document/ wtp056059.pdf Accessed August 31, 2015.
38. Thorogood A, Joly Y, Knoppers BM, et al. An implementation framework for the feedback of individual research results and incidental findings in research. BMC Med Ethics 2014; 15:88.
39. Jarvik GP, Amendola LM, Berg JS, et al. Return of genomic results to research participants: The floor, the ceiling, and the choices in between. Am J Hum Genet 2014;94:818-826.
40. Centre of Genomics and Policy, McGill University. Statement of principles for the return of research results and incidental findings. Available at: www.rmga.qc.ca/en/documents/RMGA Statement-Principles-English-May272013-000.pdf Accessed August 31, 2015.
41. Knoppers BM, Deschenes M, Zawati MH, et al. Population studies: Return of research results and incidental findings Policy Statement. Eur J Hum Genet 2013;21:245-247.
42. Wolf SM, Crock BN, Van NB, et al. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med 2012;14:361-384.
43. Bredenoord AL, Onland-Moret NC, Van Delden JJ. Feedback of individual genetic results to research participants: In favor of a qualified disclosure policy. Hum Mutat 2011;32:861-867.
44. Fabsitz RR, McGuire A, Sharp RR, et al. Ethical and practical guidelines for reporting genetic research results to study participants: Updated guidelines from a National Heart, Lung, and Blood Institute working group. Circ Cardiovasc Genet 2010;3:574-580.
45. Knoppers BM, Avard D, Senecal K, et al. Return of wholegenome sequencing results in paediatric research: A statement of the P3G international paediatrics platform. Eur J Hum Genet 2014;22:3-5.
46. Holm IA, Savage SK, Green RC, et al. Guidelines for return of research results from pediatric genomic studies: Deliberations of the Boston Children's Hospital Gene Partnership Informed Cohort Oversight Board. Genet Med 2014;16:547-552.
47. Presidential Commission for the Study of Bioethical Issues. Anticipate and communicate: Ethical management of incidental and secondary findings in the clinical, research, and direct-to-consumer contexts. Available at: http://bioethics.gov/ sites/default/files/FINALAnticipateCommunicate-PCSBI-0. pdf Accessed August 31, 2015.
48. Skirton H, Lewis C, Kent A, et al. Genetic education and the challenge of genomic medicine: Development of core competences to support preparation of health professionals in Europe. Eur J Hum Genet 2010;18:972-977.
49. Williams H, Spencer K, Sanders C, et al. Dynamic consent: A possible solution to improve patient confidence and trust in how electronic patient records are used in medical research. JMIR Med Inform 2015;3:e3.
50. Coriell Personalized Medicine Collaborative. Available at: https://cpmc.coriell.org/ Accessed August 31, 2015.
51. Graves KD, Sinicrope PS, Esplen MJ, et al. Communication of genetic test results to family and health-care providers following disclosure of research results. Genet Med 2014;16:294-301.
52. IBM Watson. Available at: www.ibm.com/smarterplanet/ us/en/ibmwatson/index.html Accessed August 31, 2015.
53. European Commission. Public Consultation "Science 2.0". Science in transition. Available at: http://ec.europa.eu/research/ consultations/science-2.0/background.pdf Accessed August 31, 2015.
54. Council of Europe Committee on Bioethics. Compilation of replies to the public consultation concerning the Working document on research on biological materials of human origin. Available at: www.coe.int/t/dg3/healthbioethic/Activities/ 10-Biobanks/INF(2014)13%20compilation%20biobanks%20e .pdf Accessed August 31, 2015.
55. Otten E, Plantinga M, Birnie E, et al. Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature. Genet Med 2015;17:668-678.
56. European Commission. Horizon 2020. The EU Framework Programme for Research and Innovation. Available at: http:// ec.europa.eu/programmes/horizon2020/en/what-horizon-2020 Accessed August 31, 2015.
57. The Rudy Study. Available at: https://research.ndorms.ox .ac.uk/rudy/ Accessed December 18, 2015.
58. Food and Drug Administration. Developing analytical standards for NGS testing. Available at: www.fda.gov/downloads/ MedicalDevices/NewsEvents/WorkshopsConferences/UCM46 8521.pdf Accessed 17, February 2016.
59. Truven Health Analytics NPR. Health Poll. Data Privacy. Available at: http://truvenhealth.com/Portals/0/NPR-Truven-Health-Poll/NPRPulseDataPrivacy-Nov2014.pdf Accessed August 31, 2015.
60. Free the data. Available at: www.free-the-data.org/ Accessed August 31, 2015.
61. Apple. ResearchKit. Available at: www.apple.com/research kit/ Accessed August 31, 2015.